Search by Drug Name or NDC

    NDC 59676-0701-01 SIRTURO 100 mg/1 Details

    SIRTURO 100 mg/1

    SIRTURO is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Products, LP. The primary component is BEDAQUILINE FUMARATE.

    Product Information

    NDC 59676-0701
    Product ID 59676-701_07ec67e8-a3f2-a416-e063-6294a90a881e
    Associated GPIs 09000015100320
    GCN Sequence Number 070413
    GCN Sequence Number Description bedaquiline fumarate TABLET 100 MG ORAL
    HIC3 W1G
    HIC3 Description ANTITUBERCULAR ANTIBIOTICS
    GCN 33934
    HICL Sequence Number 039895
    HICL Sequence Number Description BEDAQUILINE FUMARATE
    Brand/Generic Brand
    Proprietary Name SIRTURO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bedaquiline Fumarate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name BEDAQUILINE FUMARATE
    Labeler Name Janssen Products, LP
    Pharmaceutical Class Diarylquinoline Antimycobacterial [EPC], Diarylquinolines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204384
    Listing Certified Through 2024-12-31

    Package

    NDC 59676-0701-01 (59676070101)

    NDC Package Code 59676-701-01
    Billing NDC 59676070101
    Package 188 TABLET in 1 BOTTLE (59676-701-01)
    Marketing Start Date 2012-12-28
    NDC Exclude Flag N
    Pricing Information N/A